日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Identification and characterization of 4-chloro-N-(2-{[5-trifluoromethyl)-2-pyridyl]sulfonyl}ethyl)benzamide (GSK3787), a selective and irreversible peroxisome proliferator-activated receptor delta (PPARdelta) antagonist

4-氯-N-(2-{[5-三氟甲基)-2-吡啶基]磺酰基}乙基)苯甲酰胺 (GSK3787) 的鉴别和表征,一种选择性和不可逆的过氧化物酶体增殖激活受体 delta (PPARdelta) 拮抗剂

Barry G Shearer, Robert W Wiethe, Adam Ashe, Andrew N Billin, James M Way, Thomas B Stanley, Craig D Wagner, Robert X Xu, Lisa M Leesnitzer, Raymond V Merrihew, Todd W Shearer, Michael R Jeune, John C Ulrich, Timothy M Willson